Biosidus amplía su capacidad de fabricación de productos biológicos

Summary

Biosidus announced an expansion of its biologic drug manufacturing capacity and strengthened its global supply capacity for agalsidase beta, a rare disease therapeutic. The announcement reflects the company's operational expansion efforts.